← Leaderboards
E Brian Butler
Baylor College Of Medicine
$91,101
Attributed
$91,101
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.7K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$91,101 · 2
By mechanism
M01$91,101 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Susan M Blaney$10,519,074
- Peter T Scardino$5,501,749
- Timothy C Thompson$13,464,867
- Norman Michael Greenberg$14,007,258
- William Thomas Shearer$34,592,326
Others in their field
Top investigators on “Alphaherpesvirinae”
- Gregory Allan Smith · Albert Einstein College Of Medicine$4,780,726
- Bernard Roizman · University Of Alabama At Birmingham$4,673,409
- Donald M Coen · University Of Pennsylvania$4,391,905
- Barry T. Rouse · University Of Tennessee Knoxville$2,726,346
- David J. Fink · University Of Pittsburgh At Pittsburgh$2,481,223
- Saul J Silverstein · Columbia University Health Sciences$2,460,770
Research focus
AlphaherpesvirinaeAntiviral AgentsClinical ResearchClinical Trial Phase IClinical Trial Phase IiCombination Cancer TherapyGene TherapyHuman SubjectMaleNeoplasm /Cancer Radiation TherapyPatient Oriented ResearchProstate NeoplasmsThymidine KinaseValacyclovir
Grant awards (3)
PHASE I-II STUDY ON HSV-TK GENE THERAPY + RADIOTHERAPY FOR PROSTATE CANCER$1,861
M01 · FY2006 · RR · contact PI
PHASE I-II STUDY ON HSV-TK GENE THERAPY + RADIOTHERAPY FOR PROSTATE CANCER$34,718
M01 · FY2005 · RR
Phase I-II Study on HSV-tk Gene Therapy + Radiotherapy for Prostate Cancer$54,522
M01 · FY2004 · RR